Free Trial

SVB Leerink Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Leerink. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Leerink.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$121.61
+2.8%
7/11/2024Target Raised bySVB Leerink-Outperform -> Outperform$106.00 -> $127.00LowView details for SVB Leerink rating of Lantheus (NASDAQ:LNTH) on 7/11/2024
Encompass Health Co. stock logo
EHC
Encompass Health
$86.83
-0.4%
7/10/2024Initiated bySVB Leerink-Outperform$100.00LowView details for SVB Leerink rating of Encompass Health (NYSE:EHC) on 7/10/2024
HilleVax, Inc. stock logo
HLVX
HilleVax
$1.85
+1.1%
7/9/2024Downgraded bySVB Leerink-Outperform -> Market Perform$28.00 -> $2.00LowView details for SVB Leerink rating of HilleVax (NASDAQ:HLVX) on 7/9/2024
Revvity, Inc. stock logo
RVTY
Revvity
$113.38
+0.2%
7/8/2024Initiated bySVB Leerink-Outperform$125.00LowView details for SVB Leerink rating of Revvity (NYSE:RVTY) on 7/8/2024
Schrödinger, Inc. stock logo
SDGR
Schrödinger
$23.17
-3.5%
7/2/2024Initiated bySVB Leerink-Outperform$29.00LowView details for SVB Leerink rating of Schrödinger (NASDAQ:SDGR) on 7/2/2024
Cencora, Inc. stock logo
COR
Cencora
$225.14
-0.1%
6/27/2024Reiterated bySVB Leerink-Outperform -> Outperform$275.00 -> $275.00LowView details for SVB Leerink rating of Cencora (NYSE:COR) on 6/27/2024
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$240.02
-3.9%
6/25/2024Target Raised bySVB Leerink-Market Perform -> Market Perform$138.00 -> $159.00LowView details for SVB Leerink rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 6/25/2024
Solid Biosciences Inc. stock logo
SLDB
Solid Biosciences
$8.91
-7.6%
6/24/2024Upgraded bySVB Leerink-Market Perform -> Outperform$12.00 -> $12.00LowView details for SVB Leerink rating of Solid Biosciences (NASDAQ:SLDB) on 6/24/2024
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$146.90
-1.4%
6/24/2024Target Raised bySVB Leerink-Outperform -> Outperform$165.00 -> $230.00LowView details for SVB Leerink rating of Sarepta Therapeutics (NASDAQ:SRPT) on 6/24/2024
Mereo BioPharma Group plc stock logo
MREO
Mereo BioPharma Group
$3.89
-4.9%
6/20/2024Target Raised bySVB Leerink-Outperform -> Outperform$6.00 -> $8.00LowView details for SVB Leerink rating of Mereo BioPharma Group (NASDAQ:MREO) on 6/20/2024
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
$27.25
+2.1%
5/21/2024Initiated bySVB Leerink-Outperform$54.00LowView details for SVB Leerink rating of Q32 Bio (NASDAQ:QTTB) on 5/21/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$0.74
-1.3%
5/15/2024Reiterated bySVB Leerink-Outperform -> Market Perform$3.00 -> $1.00LowView details for SVB Leerink rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/15/2024
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$4.74
+1.7%
5/14/2024Downgraded bySVB Leerink-Outperform -> Market Perform$8.25 -> $5.00LowView details for SVB Leerink rating of AirSculpt Technologies (NASDAQ:AIRS) on 5/14/2024
Enhabit, Inc. stock logo
EHAB
Enhabit
$9.69
+0.4%
5/14/2024Upgraded bySVB Leerink-Underperform -> Market Perform$8.50LowView details for SVB Leerink rating of Enhabit (NYSE:EHAB) on 5/14/2024
Aquestive Therapeutics, Inc. stock logo
AQST
Aquestive Therapeutics
$3.10
+2.0%
5/10/2024Initiated bySVB Leerink-Outperform$8.00LowView details for SVB Leerink rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/10/2024
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
$27.09
-1.1%
5/8/2024Upgraded bySVB Leerink-Market Perform -> Outperform$25.00 -> $35.00LowView details for SVB Leerink rating of Myriad Genetics (NASDAQ:MYGN) on 5/8/2024
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$114.36
-5.1%
5/6/2024Upgraded bySVB Leerink-Underperform -> Market Perform$50.00 -> $97.00LowView details for SVB Leerink rating of Blueprint Medicines (NASDAQ:BPMC) on 5/6/2024
CVS Health Co. stock logo
CVS
CVS Health
$61.63
+2.6%
5/1/2024Reiterated bySVB Leerink-Outperform -> Market Perform$87.00 -> $60.00LowView details for SVB Leerink rating of CVS Health (NYSE:CVS) on 5/1/2024
Lexicon Pharmaceuticals, Inc. stock logo
LXRX
Lexicon Pharmaceuticals
$2.13
-4.5%
4/30/2024Initiated bySVB Leerink-Outperform$5.00LowView details for SVB Leerink rating of Lexicon Pharmaceuticals (NASDAQ:LXRX) on 4/30/2024
XOMA Co. stock logo
XOMA
XOMA
$28.72
+6.4%
4/29/2024Initiated bySVB Leerink-Outperform$40.00LowView details for SVB Leerink rating of XOMA (NASDAQ:XOMA) on 4/29/2024
Neurogene Inc. stock logo
NGNE
Neurogene
$44.34
-3.1%
4/29/2024Initiated bySVB Leerink-Outperform$46.00LowView details for SVB Leerink rating of Neurogene (NASDAQ:NGNE) on 4/29/2024
Immunocore Holdings plc stock logo
IMCR
Immunocore
$39.00
-6.0%
4/29/2024Initiated bySVB Leerink-Outperform$74.00LowView details for SVB Leerink rating of Immunocore (NASDAQ:IMCR) on 4/29/2024
CureVac stock logo
CVAC
CureVac
$3.65
+2.5%
4/25/2024Downgraded bySVB Leerink-Outperform -> Market Perform$12.00 -> $4.00LowView details for SVB Leerink rating of CureVac (NASDAQ:CVAC) on 4/25/2024
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$45.63
-2.9%
4/25/2024Upgraded bySVB Leerink-Market Perform -> Outperform$34.00 -> $45.00LowView details for SVB Leerink rating of Tandem Diabetes Care (NASDAQ:TNDM) on 4/25/2024
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$18.42
+2.3%
4/23/2024Initiated bySVB Leerink-Outperform$39.00LowView details for SVB Leerink rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$34.46
-0.1%
4/16/2024Initiated bySVB Leerink-Outperform$47.00LowView details for SVB Leerink rating of AnaptysBio (NASDAQ:ANAB) on 4/16/2024
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$8.39
-1.2%
4/15/2024Initiated bySVB Leerink-Outperform$20.00LowView details for SVB Leerink rating of Mind Medicine (MindMed) (NASDAQ:MNMD) on 4/15/2024
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
$21.81
-0.7%
4/15/2024Initiated bySVB Leerink-Outperform$32.00LowView details for SVB Leerink rating of LENZ Therapeutics (NASDAQ:LENZ) on 4/15/2024
Ardelyx, Inc. stock logo
ARDX
Ardelyx
$5.75
-7.4%
4/5/2024Initiated bySVB Leerink-Outperform$14.00LowView details for SVB Leerink rating of Ardelyx (NASDAQ:ARDX) on 4/5/2024
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$10.09
-4.6%
4/3/2024Initiated bySVB Leerink-Outperform$25.00LowView details for SVB Leerink rating of Larimar Therapeutics (NASDAQ:LRMR) on 4/3/2024
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$80.50
-4.2%
4/1/2024Upgraded bySVB Leerink-Market Perform -> Outperform$69.00 -> $110.00LowView details for SVB Leerink rating of Nuvalent (NASDAQ:NUVL) on 4/1/2024
Sagimet Biosciences Inc. stock logo
SGMT
Sagimet Biosciences
$3.40
-6.8%
3/25/2024Initiated bySVB Leerink-Outperform$26.00LowView details for SVB Leerink rating of Sagimet Biosciences (NASDAQ:SGMT) on 3/25/2024
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$11.85
+1.0%
3/18/2024Target Lowered bySVB Leerink-Market Perform -> Market Perform$23.00 -> $22.00LowView details for SVB Leerink rating of Walgreens Boots Alliance (NASDAQ:WBA) on 3/18/2024
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$38.37
-4.1%
3/18/2024Target Lowered bySVB Leerink-Outperform -> Outperform$44.00 -> $43.00LowView details for SVB Leerink rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 3/18/2024
Regulus Therapeutics Inc. stock logo
RGLS
Regulus Therapeutics
$1.70
-4.5%
3/18/2024Initiated bySVB Leerink-Outperform$6.00LowView details for SVB Leerink rating of Regulus Therapeutics (NASDAQ:RGLS) on 3/18/2024
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$0.56
-5.1%
3/14/2024Downgraded bySVB Leerink-Outperform -> Market Perform$9.00 -> $2.00LowView details for SVB Leerink rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$2.12
-10.2%
3/11/2024Downgraded bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 3/11/2024
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.28
-2.1%
3/6/2024Upgraded bySVB Leerink-Market Perform -> Outperform$37.00LowView details for SVB Leerink rating of REGENXBIO (NASDAQ:RGNX) on 3/6/2024
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$11.33
-0.1%
3/5/2024Upgraded bySVB Leerink-Market Perform -> Outperform$6.00 -> $18.00LowView details for SVB Leerink rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/5/2024
Kyverna Therapeutics, Inc. stock logo
KYTX
Kyverna Therapeutics
$10.50
-5.1%
3/4/2024Initiated bySVB Leerink-Outperform$48.00LowView details for SVB Leerink rating of Kyverna Therapeutics (NASDAQ:KYTX) on 3/4/2024
Could You Retire on a Single AI Stock (trading for only $15)? (Ad)

This is the perfect AI stock...And it's currently trading for only $15. With just one investment in this company, you could potentially set yourself up for massive financial gains.

Click here for the ticker >>>
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$11.85
+1.0%
2/26/2024Initiated bySVB Leerink-Market Perform$23.00LowView details for SVB Leerink rating of Walgreens Boots Alliance (NASDAQ:WBA) on 2/26/2024
DENTSPLY SIRONA Inc. stock logo
XRAY
DENTSPLY SIRONA
$27.54
+2.7%
2/26/2024Initiated bySVB Leerink-Outperform$42.00LowView details for SVB Leerink rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 2/26/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
$13.03
2/26/2024Initiated bySVB Leerink-Outperform$14.00LowView details for SVB Leerink rating of R1 RCM (NASDAQ:RCM) on 2/26/2024
Progyny, Inc. stock logo
PGNY
Progyny
$29.58
-1.4%
2/26/2024Initiated bySVB Leerink-Outperform$49.00LowView details for SVB Leerink rating of Progyny (NASDAQ:PGNY) on 2/26/2024
Premier, Inc. stock logo
PINC
Premier
$19.78
+3.1%
2/26/2024Initiated bySVB Leerink-Market Perform$22.50LowView details for SVB Leerink rating of Premier (NASDAQ:PINC) on 2/26/2024
Patterson Companies, Inc. stock logo
PDCO
Patterson Companies
$26.38
+3.9%
2/26/2024Initiated bySVB Leerink-Outperform$36.00LowView details for SVB Leerink rating of Patterson Companies (NASDAQ:PDCO) on 2/26/2024
Owens & Minor, Inc. stock logo
OMI
Owens & Minor
$14.81
+2.6%
2/26/2024Initiated bySVB Leerink-Market Perform$24.00LowView details for SVB Leerink rating of Owens & Minor (NYSE:OMI) on 2/26/2024
McKesson Co. stock logo
MCK
McKesson
$582.34
-0.3%
2/26/2024Initiated bySVB Leerink-Outperform$600.00LowView details for SVB Leerink rating of McKesson (NYSE:MCK) on 2/26/2024
Laboratory Co. of America Holdings stock logo
LH
Laboratory Co. of America
$215.87
-0.3%
2/26/2024Initiated bySVB Leerink-Outperform$260.00LowView details for SVB Leerink rating of Laboratory Co. of America (NYSE:LH) on 2/26/2024
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$230.29
-1.2%
2/26/2024Initiated bySVB Leerink-Outperform$290.00LowView details for SVB Leerink rating of IQVIA (NYSE:IQV) on 2/26/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$22.00
-4.8%
2/26/2024Initiated bySVB Leerink-Market Perform$10.00LowView details for SVB Leerink rating of Hims & Hers Health (NYSE:HIMS) on 2/26/2024
GoodRx Holdings, Inc. stock logo
GDRX
GoodRx
$8.25
-1.4%
2/26/2024Initiated bySVB Leerink-Outperform$8.00LowView details for SVB Leerink rating of GoodRx (NASDAQ:GDRX) on 2/26/2024
Envista Holdings Co. stock logo
NVST
Envista
$17.18
+2.0%
2/26/2024Initiated bySVB Leerink-Underperform$19.00LowView details for SVB Leerink rating of Envista (NYSE:NVST) on 2/26/2024
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$10.03
-0.6%
2/26/2024Initiated bySVB Leerink-Market Perform$17.00LowView details for SVB Leerink rating of Teladoc Health (NYSE:TDOC) on 2/26/2024
CVS Health Co. stock logo
CVS
CVS Health
$61.63
+2.6%
2/26/2024Initiated bySVB Leerink-Outperform$88.00LowView details for SVB Leerink rating of CVS Health (NYSE:CVS) on 2/26/2024
Henry Schein, Inc. stock logo
HSIC
Henry Schein
$71.22
+5.4%
2/26/2024Initiated bySVB Leerink-Market Perform$78.00LowView details for SVB Leerink rating of Henry Schein (NASDAQ:HSIC) on 2/26/2024
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$148.55
0.0%
2/26/2024Initiated bySVB Leerink-Market Perform$135.00LowView details for SVB Leerink rating of Quest Diagnostics (NYSE:DGX) on 2/26/2024
Doximity, Inc. stock logo
DOCS
Doximity
$28.99
-1.2%
2/26/2024Initiated bySVB Leerink-Market Perform$32.00LowView details for SVB Leerink rating of Doximity (NASDAQ:DOCS) on 2/26/2024
Certara, Inc. stock logo
CERT
Certara
$16.55
+0.3%
2/26/2024Initiated bySVB Leerink-Market Perform$19.00LowView details for SVB Leerink rating of Certara (NASDAQ:CERT) on 2/26/2024
Cencora, Inc. stock logo
COR
Cencora
$225.14
-0.1%
2/26/2024Initiated bySVB Leerink-Outperform$261.00LowView details for SVB Leerink rating of Cencora (NYSE:COR) on 2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$96.01
+0.6%
2/26/2024Initiated bySVB Leerink-Outperform$125.00LowView details for SVB Leerink rating of Cardinal Health (NYSE:CAH) on 2/26/2024
Align Technology, Inc. stock logo
ALGN
Align Technology
$250.58
+1.2%
2/26/2024Initiated bySVB Leerink-Market Perform$310.00LowView details for SVB Leerink rating of Align Technology (NASDAQ:ALGN) on 2/26/2024
Accolade, Inc. stock logo
ACCD
Accolade
$3.84
-2.8%
2/26/2024Initiated bySVB Leerink-Outperform$16.00LowView details for SVB Leerink rating of Accolade (NASDAQ:ACCD) on 2/26/2024
Applied Therapeutics, Inc. stock logo
APLT
Applied Therapeutics
$5.67
+0.7%
2/22/2024Initiated bySVB Leerink-Outperform$12.00LowView details for SVB Leerink rating of Applied Therapeutics (NASDAQ:APLT) on 2/22/2024
RAPT Therapeutics, Inc. stock logo
RAPT
RAPT Therapeutics
$3.64
-3.2%
2/21/2024Downgraded bySVB Leerink-Outperform -> Market Perform$42.00 -> $10.00LowView details for SVB Leerink rating of RAPT Therapeutics (NASDAQ:RAPT) on 2/21/2024
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
$11.85
-1.2%
2/20/2024Initiated bySVB Leerink-Outperform$15.00LowView details for SVB Leerink rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024
enGene Holdings Inc. stock logo
ENGN
enGene
$9.07
+0.7%
2/20/2024Initiated bySVB Leerink-Outperform$31.00LowView details for SVB Leerink rating of enGene (NASDAQ:ENGN) on 2/20/2024
Synlogic, Inc. stock logo
SYBX
Synlogic
$1.65
+5.8%
2/9/2024Reiterated bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of Synlogic (NASDAQ:SYBX) on 2/9/2024
Amgen Inc. stock logo
AMGN
Amgen
$335.67
+0.8%
2/7/2024Downgraded bySVB Leerink-Outperform -> Market Perform$324.00 -> $318.00LowView details for SVB Leerink rating of Amgen (NASDAQ:AMGN) on 2/7/2024
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$331.44
+1.0%
2/5/2024Initiated bySVB Leerink-Outperform$330.00LowView details for SVB Leerink rating of United Therapeutics (NASDAQ:UTHR) on 2/5/2024
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.77
-2.9%
1/31/2024Upgraded bySVB Leerink-Market Perform -> Outperform$5.00 -> $18.00LowView details for SVB Leerink rating of 2seventy bio (NASDAQ:TSVT) on 1/31/2024
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$7.51
-6.4%
1/30/2024Initiated bySVB Leerink-Outperform$22.00LowView details for SVB Leerink rating of NeuroPace (NASDAQ:NPCE) on 1/30/2024
Immunome, Inc. stock logo
IMNM
Immunome
$13.99
-4.6%
1/29/2024Initiated bySVB Leerink-Outperform$30.00LowView details for SVB Leerink rating of Immunome (NASDAQ:IMNM) on 1/29/2024
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$3.27
-8.1%
1/23/2024Initiated bySVB Leerink-Outperform$12.00LowView details for SVB Leerink rating of Pyxis Oncology (NASDAQ:PYXS) on 1/23/2024
Axonics, Inc. stock logo
AXNX
Axonics
$68.00
+0.0%
1/12/2024Reiterated bySVB Leerink-Outperform -> Market Perform$71.00LowView details for SVB Leerink rating of Axonics (NASDAQ:AXNX) on 1/12/2024
agilon health, inc. stock logo
AGL
agilon health
$7.36
-1.3%
1/8/2024Downgraded bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of agilon health (NYSE:AGL) on 1/8/2024
AlloVir, Inc. stock logo
ALVR
AlloVir
$0.81
-1.2%
12/22/2023Downgraded bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of AlloVir (NASDAQ:ALVR) on 12/22/2023
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$5.91
-1.3%
12/19/2023Upgraded bySVB Leerink-Market Perform -> Outperform$5.00 -> $12.00LowView details for SVB Leerink rating of Wave Life Sciences (NASDAQ:WVE) on 12/19/2023
Reneo Pharmaceuticals, Inc. stock logo
RPHM
Reneo Pharmaceuticals
$1.49
-2.0%
12/15/2023Reiterated bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of Reneo Pharmaceuticals (NASDAQ:RPHM) on 12/15/2023
Incyte Co. stock logo
INCY
Incyte
$65.30
+2.0%
12/13/2023Upgraded bySVB Leerink-Market Perform -> Outperform$78.00LowView details for SVB Leerink rating of Incyte (NASDAQ:INCY) on 12/13/2023
Nanobiotix S.A. stock logo
NBTX
Nanobiotix
$5.42
-2.2%
12/8/2023Initiated bySVB Leerink-Outperform$11.00LowView details for SVB Leerink rating of Nanobiotix (NASDAQ:NBTX) on 12/8/2023
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
$3.64
-4.2%
11/30/2023Initiated bySVB Leerink-Outperform$7.00LowView details for SVB Leerink rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/30/2023
Lexeo Therapeutics, Inc. stock logo
LXEO
Lexeo Therapeutics
$11.32
-10.4%
11/28/2023Initiated bySVB Leerink-Outperform$19.00LowView details for SVB Leerink rating of Lexeo Therapeutics (NASDAQ:LXEO) on 11/28/2023
ABIVAX Société Anonyme stock logo
ABVX
ABIVAX Société Anonyme
$13.28
-1.2%
11/14/2023Initiated bySVB Leerink-Outperform$20.00LowView details for SVB Leerink rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 11/14/2023
Zentalis Pharmaceuticals, Inc. stock logo
ZNTL
Zentalis Pharmaceuticals
$4.29
-6.1%
11/7/2023Downgraded bySVB Leerink-Outperform -> Market Perform$15.00LowView details for SVB Leerink rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/7/2023
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.77
-2.9%
10/30/2023Downgraded bySVB Leerink-Outperform -> Market Perform$6.00LowView details for SVB Leerink rating of 2seventy bio (NASDAQ:TSVT) on 10/30/2023
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$26.93
-1.3%
10/20/2023Downgraded bySVB Leerink-Outperform -> Market Perform$75.00 -> $20.00LowView details for SVB Leerink rating of Beam Therapeutics (NASDAQ:BEAM) on 10/20/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$18.20
-32.0%
10/18/2023Upgraded bySVB Leerink-Market Perform -> Outperform$24.00LowView details for SVB Leerink rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 10/18/2023
AxoGen, Inc. stock logo
AXGN
AxoGen
$9.48
+3.3%
10/16/2023Initiated bySVB Leerink-Outperform$9.00LowView details for SVB Leerink rating of AxoGen (NASDAQ:AXGN) on 10/16/2023
Axonics, Inc. stock logo
AXNX
Axonics
$68.00
+0.0%
10/16/2023Initiated bySVB Leerink-Outperform$70.00LowView details for SVB Leerink rating of Axonics (NASDAQ:AXNX) on 10/16/2023
Prepare for crypto’s next bull run now (Ad)

The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…

Check out the new "Crypto Bull Run Millionaire Blueprint" now!
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$71.23
+2.1%
10/16/2023Initiated bySVB Leerink-Outperform$37.00LowView details for SVB Leerink rating of PROCEPT BioRobotics (NASDAQ:PRCT) on 10/16/2023
DexCom, Inc. stock logo
DXCM
DexCom
$114.61
-1.2%
10/16/2023Initiated bySVB Leerink-Outperform$110.00LowView details for SVB Leerink rating of DexCom (NASDAQ:DXCM) on 10/16/2023
Edwards Lifesciences Co. stock logo
EW
Edwards Lifesciences
$87.32
-0.5%
10/16/2023Initiated bySVB Leerink-Market Perform$75.00LowView details for SVB Leerink rating of Edwards Lifesciences (NYSE:EW) on 10/16/2023
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.53
-0.2%
10/16/2023Initiated bySVB Leerink-Market Perform$159.00LowView details for SVB Leerink rating of Inspire Medical Systems (NYSE:INSP) on 10/16/2023
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$45.63
-2.9%
10/16/2023Initiated bySVB Leerink-Market Perform$21.00LowView details for SVB Leerink rating of Tandem Diabetes Care (NASDAQ:TNDM) on 10/16/2023
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$426.23
-2.7%
10/16/2023Initiated bySVB Leerink-Outperform$342.00LowView details for SVB Leerink rating of Intuitive Surgical (NASDAQ:ISRG) on 10/16/2023
Vericel Co. stock logo
VCEL
Vericel
$51.72
-1.0%
10/16/2023Initiated bySVB Leerink-Outperform$42.00LowView details for SVB Leerink rating of Vericel (NASDAQ:VCEL) on 10/16/2023
Insulet Co. stock logo
PODD
Insulet
$197.65
-1.9%
10/16/2023Initiated bySVB Leerink-Outperform$184.00LowView details for SVB Leerink rating of Insulet (NASDAQ:PODD) on 10/16/2023
Amgen Inc. stock logo
AMGN
Amgen
$335.67
+0.8%
10/11/2023Upgraded bySVB Leerink-Market Perform -> Outperform$267.00 -> $318.00LowView details for SVB Leerink rating of Amgen (NASDAQ:AMGN) on 10/11/2023
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$144.65
-1.9%
10/6/2023Target Raised bySVB LeerinkAnalyst M. Goodman$125.00 -> $135.00LowView details for SVB Leerink rating of Neurocrine Biosciences (NASDAQ:NBIX) on 10/6/2023
Structure Therapeutics Inc. stock logo
GPCR
Structure Therapeutics
$38.34
-14.2%
9/29/2023Target Raised bySVB Leerink-$46.00 -> $97.00LowView details for SVB Leerink rating of Structure Therapeutics (NASDAQ:GPCR) on 9/29/2023
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$11.33
-0.1%
9/21/2023Downgraded bySVB Leerink-Outperform -> Market PerformLowView details for SVB Leerink rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 9/21/2023
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$34.19
+0.1%
9/18/2023Target Lowered bySVB LeerinkAnalyst J. Schwartz$44.00 -> $30.00LowView details for SVB Leerink rating of PTC Therapeutics (NASDAQ:PTCT) on 9/18/2023
Spruce Biosciences, Inc. stock logo
SPRB
Spruce Biosciences
$0.56
-5.1%
9/8/2023Upgraded bySVB Leerink-Market Perform -> Outperform$3.00 -> $9.00LowView details for SVB Leerink rating of Spruce Biosciences (NASDAQ:SPRB) on 9/8/2023
Galecto, Inc. stock logo
GLTO
Galecto
$0.57
8/15/2023Reiterated bySVB Leerink-Outperform -> Market Perform$13.00 -> $2.00LowView details for SVB Leerink rating of Galecto (NASDAQ:GLTO) on 8/15/2023
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
$4.46
-2.0%
8/15/2023Reiterated bySVB Leerink-Outperform -> Market Perform$6.00LowView details for SVB Leerink rating of Design Therapeutics (NASDAQ:DSGN) on 8/15/2023
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$56.79
+0.1%
8/15/2023Initiated bySVB Leerink-Outperform$58.00LowView details for SVB Leerink rating of Cytokinetics (NASDAQ:CYTK) on 8/15/2023
Exelixis, Inc. stock logo
EXEL
Exelixis
$22.51
-1.1%
8/8/2023Initiated bySVB Leerink-Market Perform$18.00LowView details for SVB Leerink rating of Exelixis (NASDAQ:EXEL) on 8/8/2023
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$40.71
-4.5%
8/8/2023Initiated bySVB Leerink-Outperform$33.00LowView details for SVB Leerink rating of IDEAYA Biosciences (NASDAQ:IDYA) on 8/8/2023
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$80.50
-4.2%
8/8/2023Initiated bySVB Leerink-Market Perform$42.00LowView details for SVB Leerink rating of Nuvalent (NASDAQ:NUVL) on 8/8/2023
NovoCure Limited stock logo
NVCR
NovoCure
$19.11
-0.9%
8/4/2023Initiated bySVB Leerink-Outperform$51.00LowView details for SVB Leerink rating of NovoCure (NASDAQ:NVCR) on 8/4/2023
Belite Bio, Inc stock logo
BLTE
Belite Bio
$48.16
-0.8%
7/26/2023Reiterated bySVB LeerinkAnalyst M. GoodmanOutperform$25.00LowView details for SVB Leerink rating of Belite Bio (NASDAQ:BLTE) on 7/26/2023
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$144.65
-1.9%
7/24/2023Upgraded bySVB LeerinkAnalyst M. GoodmanMarket Perform -> OutperformLowView details for SVB Leerink rating of Neurocrine Biosciences (NASDAQ:NBIX) on 7/24/2023
Cryoport, Inc. stock logo
CYRX
Cryoport
$8.47
-2.3%
7/13/2023Downgraded bySVB LeerinkAnalyst P. SoudaOutperform -> Market PerformLowView details for SVB Leerink rating of Cryoport (NASDAQ:CYRX) on 7/13/2023
Bristol-Myers Squibb stock logo
BMY
Bristol-Myers Squibb
$43.17
+4.8%
7/10/2023Reiterated bySVB LeerinkAnalyst D. RisingerMarket PerformLowView details for SVB Leerink rating of Bristol-Myers Squibb (NYSE:BMY) on 7/10/2023
Enhabit, Inc. stock logo
EHAB
Enhabit
$9.69
+0.4%
6/20/2023Reiterated bySVB LeerinkAnalyst W. MayoUnderperformLowView details for SVB Leerink rating of Enhabit (NYSE:EHAB) on 6/20/2023
Oculis Holding AG stock logo
OCS
Oculis
$11.73
6/12/2023Reiterated bySVB LeerinkAnalyst M. GoodmanOutperformLowView details for SVB Leerink rating of Oculis (NASDAQ:OCS) on 6/12/2023
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$114.36
-5.1%
6/5/2023Downgraded bySVB LeerinkAnalyst A. BerensMarket Perform -> UnderperformLowView details for SVB Leerink rating of Blueprint Medicines (NASDAQ:BPMC) on 6/5/2023
Elevation Oncology, Inc. stock logo
ELEV
Elevation Oncology
$2.89
-3.3%
5/30/2023Upgraded bySVB LeerinkAnalyst A. BerensMarket Perform -> OutperformLowView details for SVB Leerink rating of Elevation Oncology (NASDAQ:ELEV) on 5/30/2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$0.74
-1.3%
5/12/2023Upgraded bySVB LeerinkAnalyst D. GrayboschMarket Perform -> OutperformLowView details for SVB Leerink rating of Bolt Biotherapeutics (NASDAQ:BOLT) on 5/12/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.02
-5.1%
5/12/2023Downgraded bySVB LeerinkAnalyst M. ForooharOutperform -> Market PerformLowView details for SVB Leerink rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 5/12/2023
Danaher Co. stock logo
DHR
Danaher
$251.27
-0.3%
5/1/2023Reiterated bySVB LeerinkAnalyst P. SoudaOutperformLowView details for SVB Leerink rating of Danaher (NYSE:DHR) on 5/1/2023
Prothena Co. plc stock logo
PRTA
Prothena
$23.88
-1.0%
4/24/2023Reiterated bySVB LeerinkAnalyst R. LiOutperformLowView details for SVB Leerink rating of Prothena (NASDAQ:PRTA) on 4/24/2023
Genfit S.A. stock logo
GNFT
Genfit
$4.63
+4.0%
4/14/2023Reiterated bySVB LeerinkAnalyst T. SmithOutperformLowView details for SVB Leerink rating of Genfit (NASDAQ:GNFT) on 4/14/2023
Connect Biopharma Holdings Limited stock logo
CNTB
Connect Biopharma
$1.29
+1.6%
4/12/2023Reiterated bySVB LeerinkAnalyst T. SmithOutperformLowView details for SVB Leerink rating of Connect Biopharma (NASDAQ:CNTB) on 4/12/2023
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$28.02
-5.1%
4/12/2023Upgraded bySVB LeerinkAnalyst M. ForooharMarket Perform -> OutperformLowView details for SVB Leerink rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 4/12/2023
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$33.24
-0.3%
4/11/2023Reiterated bySVB LeerinkAnalyst R. RuizMarket Perform$25.00LowView details for SVB Leerink rating of Corcept Therapeutics (NASDAQ:CORT) on 4/11/2023
Arcellx, Inc. stock logo
ACLX
Arcellx
$65.51
-0.6%
3/30/2023Target Raised bySVB Leerink-Outperform$35.00 -> $39.00LowView details for SVB Leerink rating of Arcellx (NASDAQ:ACLX) on 3/30/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$104.71
+1.9%
3/31/2023Target Raised bySVB Leerink-Market Perform$90.00 -> $102.00LowView details for SVB Leerink rating of Abbott Laboratories (NYSE:ABT) on 3/31/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$1,085.62
-0.9%
3/27/2023Upgraded bySVB LeerinkAnalyst D. RisingerMarket Perform -> OutperformLowView details for SVB Leerink rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 3/27/2023
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$34.19
+0.1%
3/17/2023Reiterated bySVB LeerinkAnalyst J. SchwartzMarket Perform$48.00LowView details for SVB Leerink rating of PTC Therapeutics (NASDAQ:PTCT) on 3/17/2023
Centessa Pharmaceuticals plc stock logo
CNTA
Centessa Pharmaceuticals
$9.52
-4.1%
3/17/2023Reiterated bySVB LeerinkAnalyst D. RisingerOutperform$6.00LowView details for SVB Leerink rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/17/2023
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$54.75
-0.6%
3/16/2023Downgraded bySVB LeerinkAnalyst D. RisingerOutperform -> Market Perform$42.00LowView details for SVB Leerink rating of Halozyme Therapeutics (NASDAQ:HALO) on 3/16/2023
Morphic Holding, Inc. stock logo
MORF
Morphic
$56.27
+0.5%
3/8/2023Target Raised bySVB Leerink-Outperform$45.00 -> $56.00LowView details for SVB Leerink rating of Morphic (NASDAQ:MORF) on 3/8/2023
argenx SE stock logo
ARGX
argenx
$463.41
-1.8%
3/3/2023Target Raised bySVB Leerink-Outperform$430.00 -> $435.00LowView details for SVB Leerink rating of argenx (NASDAQ:ARGX) on 3/3/2023
Structure Therapeutics Inc. stock logo
GPCR
Structure Therapeutics
$38.34
-14.2%
2/28/2023Reiterated bySVB LeerinkAnalyst D. RisingerOutperformLowView details for SVB Leerink rating of Structure Therapeutics (NASDAQ:GPCR) on 2/28/2023
Compugen Ltd. stock logo
CGEN
Compugen
$1.86
-0.5%
2/28/2023Reiterated bySVB LeerinkAnalyst D. GrayboschOutperformLowView details for SVB Leerink rating of Compugen (NASDAQ:CGEN) on 2/28/2023
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$47.60
-0.7%
2/28/2023Reiterated bySVB LeerinkAnalyst T. SmithOutperform$36.00LowView details for SVB Leerink rating of Disc Medicine (NASDAQ:IRON) on 2/28/2023
Xencor, Inc. stock logo
XNCR
Xencor
$19.86
-2.8%
2/23/2023Reiterated bySVB LeerinkAnalyst J. ChangOutperformLowView details for SVB Leerink rating of Xencor (NASDAQ:XNCR) on 2/23/2023
Moderna, Inc. stock logo
MRNA
Moderna
$124.06
-0.9%
2/24/2023Downgraded bySVB LeerinkAnalyst M. ForooharMarket Perform -> Underperform$111.00 -> $93.00LowView details for SVB Leerink rating of Moderna (NASDAQ:MRNA) on 2/24/2023
I’m giving you the name of this investment for free (Ad)

What people don’t know is that Roivant is capitalizing on a wealth secret that goes back over a century. There are a few other public companies who are as well. Only you don’t know it… because it’s not something they openly talk about. That’s why I made this presentation. I want to expose you to a wealth-building secret that you deserve to benefit from.

You deserve to see this for your own good.
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$1.45
-1.4%
2/24/2023Target Lowered bySVB Leerink-Market Perform$5.00 -> $3.00N/AView details for SVB Leerink rating of Nektar Therapeutics (NASDAQ:NKTR) on 2/24/2023
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$114.36
-5.1%
2/24/2023Target Lowered bySVB Leerink-Market Perform$45.00 -> $38.00LowView details for SVB Leerink rating of Blueprint Medicines (NASDAQ:BPMC) on 2/24/2023
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$47.96
-3.8%
2/23/2023Target Lowered bySVB Leerink-Market Perform$34.00 -> $27.00LowView details for SVB Leerink rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/23/2023
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$10.03
-0.6%
2/23/2023Upgraded bySVB LeerinkAnalyst S. DavisMarket Perform -> Outperform$34.00LowView details for SVB Leerink rating of Teladoc Health (NYSE:TDOC) on 2/23/2023
AbbVie Inc. stock logo
ABBV
AbbVie
$175.29
+3.6%
2/10/2023Upgraded bySVB LeerinkAnalyst D. RisingerUnderperform -> Market Perform$135.00 -> $153.00LowView details for SVB Leerink rating of AbbVie (NYSE:ABBV) on 2/10/2023
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$15.82
-2.0%
2/9/2023Reiterated bySVB Leerink-Market Perform$49.00LowView details for SVB Leerink rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 2/9/2023
Connect Biopharma Holdings Limited stock logo
CNTB
Connect Biopharma
$1.29
+1.6%
2/8/2023Target Lowered bySVB Leerink-Outperform$9.00 -> $7.00LowView details for SVB Leerink rating of Connect Biopharma (NASDAQ:CNTB) on 2/8/2023
Equillium, Inc. stock logo
EQ
Equillium
$0.93
+2.2%
2/8/2023Target Lowered bySVB Leerink-Outperform$12.00 -> $7.00LowView details for SVB Leerink rating of Equillium (NASDAQ:EQ) on 2/8/2023
The Cigna Group stock logo
CI
The Cigna Group
$344.75
+1.5%
2/8/2023Target Raised bySVB Leerink-Market Perform$309.00 -> $335.00LowView details for SVB Leerink rating of The Cigna Group (NYSE:CI) on 2/8/2023
Premier, Inc. stock logo
PINC
Premier
$19.78
+3.1%
2/8/2023Target Lowered bySVB Leerink-Outperform$46.00 -> $42.00LowView details for SVB Leerink rating of Premier (NASDAQ:PINC) on 2/8/2023
Illumina, Inc. stock logo
ILMN
Illumina
$119.89
-4.3%
2/8/2023Target Raised bySVB LeerinkAnalyst P. SoudaOutperform$249.00 -> $250.00LowView details for SVB Leerink rating of Illumina (NASDAQ:ILMN) on 2/8/2023
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$488.37
-0.1%
2/8/2023Target Lowered bySVB Leerink-Outperform$374.00 -> $365.00LowView details for SVB Leerink rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/8/2023
Incyte Co. stock logo
INCY
Incyte
$65.30
+2.0%
2/8/2023Reiterated bySVB Leerink-Underperform$63.00LowView details for SVB Leerink rating of Incyte (NASDAQ:INCY) on 2/8/2023
Deciphera Pharmaceuticals, Inc. stock logo
DCPH
Deciphera Pharmaceuticals
$25.59
2/7/2023Target Raised bySVB Leerink-Outperform$28.00 -> $30.00LowView details for SVB Leerink rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 2/7/2023
Genmab A/S stock logo
GMAB
Genmab A/S
$26.83
-0.6%
2/6/2023Target Raised bySVB Leerink-Market Perform$33.00 -> $36.00LowView details for SVB Leerink rating of Genmab A/S (NASDAQ:GMAB) on 2/6/2023
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$18.20
-32.0%
2/6/2023Target Lowered bySVB LeerinkAnalyst M. ForooharMarket Perform$15.00 -> $14.00LowView details for SVB Leerink rating of 4D Molecular Therapeutics (NASDAQ:FDMT) on 2/6/2023
Immunovant, Inc. stock logo
IMVT
Immunovant
$29.98
-3.0%
2/6/2023Target Raised bySVB Leerink-Outperform$14.00 -> $21.00LowView details for SVB Leerink rating of Immunovant (NASDAQ:IMVT) on 2/6/2023
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$1,085.62
-0.9%
2/6/2023Target Raised bySVB LeerinkAnalyst D. RisingerMarket Perform$770.00 -> $834.00LowView details for SVB Leerink rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/6/2023
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$73.30
+2.3%
2/3/2023Target Raised bySVB LeerinkAnalyst D. RisingerMarket Perform$81.00 -> $91.00LowView details for SVB Leerink rating of Gilead Sciences (NASDAQ:GILD) on 2/3/2023
Bio-Techne Co. stock logo
TECH
Bio-Techne
$78.29
-1.9%
2/3/2023Target Lowered bySVB Leerink-Outperform$125.00 -> $110.00LowView details for SVB Leerink rating of Bio-Techne (NASDAQ:TECH) on 2/3/2023
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$84.66
-1.4%
2/3/2023Target Raised bySVB Leerink-Outperform$122.00 -> $130.00LowView details for SVB Leerink rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/3/2023
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$47.96
-3.8%
2/3/2023Target Raised bySVB Leerink-Market Perform$33.00 -> $34.00LowView details for SVB Leerink rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 2/3/2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$125.87
+0.3%
2/3/2023Target Raised bySVB Leerink-Outperform$120.00 -> $122.00LowView details for SVB Leerink rating of Merck & Co., Inc. (NYSE:MRK) on 2/3/2023
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
$14.97
-1.8%
2/3/2023Target Lowered bySVB Leerink-Outperform$30.00 -> $20.00LowView details for SVB Leerink rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 2/3/2023
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$555.06
-0.1%
2/2/2023Target Raised bySVB Leerink-Outperform$620.00 -> $630.00LowView details for SVB Leerink rating of Thermo Fisher Scientific (NYSE:TMO) on 2/2/2023
Hologic, Inc. stock logo
HOLX
Hologic
$78.89
+0.5%
2/2/2023Target Raised bySVB Leerink-Outperform$90.00 -> $93.00LowView details for SVB Leerink rating of Hologic (NASDAQ:HOLX) on 2/2/2023
Amgen Inc. stock logo
AMGN
Amgen
$335.67
+0.8%
2/2/2023Target Lowered bySVB Leerink-Market Perform$282.00 -> $267.00LowView details for SVB Leerink rating of Amgen (NASDAQ:AMGN) on 2/2/2023
Pfizer Inc. stock logo
PFE
Pfizer
$30.02
+1.8%
2/1/2023Target Lowered bySVB LeerinkAnalyst David RisingerMarket Perform$49.00 -> $48.00LowView details for SVB Leerink rating of Pfizer (NYSE:PFE) on 2/1/2023
OptimizeRx Co. stock logo
OPRX
OptimizeRx
$10.51
1/27/2023Reiterated bySVB LeerinkAnalyst S. DavisOutperformLowView details for SVB Leerink rating of OptimizeRx (NASDAQ:OPRX) on 1/27/2023
Omnicell, Inc. stock logo
OMCL
Omnicell
$28.66
+4.0%
1/27/2023Reiterated bySVB LeerinkAnalyst S. DavisMarket PerformLowView details for SVB Leerink rating of Omnicell (NASDAQ:OMCL) on 1/27/2023
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$230.29
-1.2%
1/27/2023Reiterated bySVB LeerinkAnalyst S. DavisOutperformLowView details for SVB Leerink rating of IQVIA (NYSE:IQV) on 1/27/2023
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$23.01
-3.9%
1/30/2023Reiterated bySVB LeerinkAnalyst M. GoodmanOutperform$50.00LowView details for SVB Leerink rating of Denali Therapeutics (NASDAQ:DNLI) on 1/30/2023
Atea Pharmaceuticals, Inc. stock logo
AVIR
Atea Pharmaceuticals
$3.87
+0.8%
1/27/2023Target Lowered bySVB Leerink-Market Perform$8.00 -> $6.00LowView details for SVB Leerink rating of Atea Pharmaceuticals (NASDAQ:AVIR) on 1/27/2023
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$15.82
-2.0%
1/27/2023Target Lowered bySVB Leerink-Market Perform$50.00 -> $49.00LowView details for SVB Leerink rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 1/27/2023
scPharmaceuticals Inc. stock logo
SCPH
scPharmaceuticals
$4.83
-4.9%
1/27/2023Target Raised bySVB LeerinkAnalyst R. RuizOutperform$12.00 -> $13.00LowView details for SVB Leerink rating of scPharmaceuticals (NASDAQ:SCPH) on 1/27/2023
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$10.27
+0.4%
1/27/2023Target Lowered bySVB LeerinkAnalyst R. RuizOutperform$45.00 -> $43.00LowView details for SVB Leerink rating of Vir Biotechnology (NASDAQ:VIR) on 1/27/2023
Xeris Biopharma Holdings, Inc. stock logo
XERS
Xeris Biopharma
$2.45
-4.7%
1/27/2023Target Lowered bySVB Leerink-Outperform$6.00 -> $5.00LowView details for SVB Leerink rating of Xeris Biopharma (NASDAQ:XERS) on 1/27/2023
Elevance Health, Inc. stock logo
ELV
Elevance Health
$520.19
-6.0%
1/26/2023Reiterated bySVB LeerinkAnalyst W. MayoOutperform$580.00LowView details for SVB Leerink rating of Elevance Health (NYSE:ELV) on 1/26/2023
Pliant Therapeutics, Inc. stock logo
PLRX
Pliant Therapeutics
$12.86
-4.7%
1/24/2023Target Raised bySVB Leerink-Outperform$33.00 -> $45.00LowView details for SVB Leerink rating of Pliant Therapeutics (NASDAQ:PLRX) on 1/24/2023
Biohaven Ltd. stock logo
BHVN
Biohaven
$36.29
-4.3%
1/24/2023Reiterated bySVB LeerinkAnalyst M. GoodmanOutperform$24.00LowView details for SVB Leerink rating of Biohaven (NYSE:BHVN) on 1/24/2023
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$125.87
+0.3%
1/23/2023Target Raised bySVB Leerink-Outperform$112.00 -> $120.00LowView details for SVB Leerink rating of Merck & Co., Inc. (NYSE:MRK) on 1/23/2023
Marinus Pharmaceuticals, Inc. stock logo
MRNS
Marinus Pharmaceuticals
$1.39
-6.1%
1/23/2023Target Lowered bySVB Leerink-Outperform$27.00 -> $23.00LowView details for SVB Leerink rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 1/23/2023
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$3.72
-1.3%
1/23/2023Target Lowered bySVB Leerink-Outperform$42.00 -> $10.00LowView details for SVB Leerink rating of Relmada Therapeutics (NASDAQ:RLMD) on 1/23/2023
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$240.02
-3.9%
1/23/2023Target Lowered bySVB Leerink-Market Perform$144.00 -> $143.00LowView details for SVB Leerink rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/23/2023
AlloVir, Inc. stock logo
ALVR
AlloVir
$0.81
-1.2%
1/23/2023Target Lowered bySVB Leerink-Outperform$25.00 -> $19.00LowView details for SVB Leerink rating of AlloVir (NASDAQ:ALVR) on 1/23/2023
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$27.99
-4.3%
1/23/2023Target Lowered bySVB Leerink-Outperform$23.00 -> $19.00LowView details for SVB Leerink rating of BridgeBio Pharma (NASDAQ:BBIO) on 1/23/2023
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$26.93
-1.3%
1/23/2023Target Lowered bySVB Leerink-Outperform$81.00 -> $77.00LowView details for SVB Leerink rating of Beam Therapeutics (NASDAQ:BEAM) on 1/23/2023
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$1.22
-9.6%
1/23/2023Target Lowered bySVB Leerink-Market Perform$9.00 -> $8.00LowView details for SVB Leerink rating of bluebird bio (NASDAQ:BLUE) on 1/23/2023
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$5.72
-4.0%
1/23/2023Target Raised bySVB LeerinkAnalyst R. BienkowskiMarket Perform$6.00 -> $7.00LowView details for SVB Leerink rating of Editas Medicine (NASDAQ:EDIT) on 1/23/2023
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$47.96
-3.8%
1/23/2023Target Raised bySVB Leerink-Market Perform$32.00 -> $33.00LowView details for SVB Leerink rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 1/23/2023
Could You Retire on a Single AI Stock (trading for only $15)? (Ad)

This is the perfect AI stock...And it's currently trading for only $15. With just one investment in this company, you could potentially set yourself up for massive financial gains.

Click here for the ticker >>>
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$27.36
+0.0%
1/23/2023Target Lowered bySVB Leerink-Outperform$86.00 -> $84.00LowView details for SVB Leerink rating of Intellia Therapeutics (NASDAQ:NTLA) on 1/23/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$23.59
+1.0%
1/23/2023Target Lowered bySVB Leerink-Outperform$50.00 -> $49.00LowView details for SVB Leerink rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 1/23/2023
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$13.28
-2.1%
1/23/2023Target Lowered bySVB Leerink-Market Perform$15.00 -> $14.00LowView details for SVB Leerink rating of REGENXBIO (NASDAQ:RGNX) on 1/23/2023
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$8.35
-2.9%
1/23/2023Target Lowered bySVB Leerink-Market Perform$9.00 -> $8.00LowView details for SVB Leerink rating of Recursion Pharmaceuticals (NASDAQ:RXRX) on 1/23/2023
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$146.90
-1.4%
1/20/2023Reiterated bySVB Leerink-Outperform$160.00LowView details for SVB Leerink rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/20/2023
Zymeworks Inc. stock logo
ZYME
Zymeworks
$10.12
-2.2%
1/20/2023Target Raised bySVB LeerinkAnalyst A. BerensMarket Perform$8.00 -> $10.00LowView details for SVB Leerink rating of Zymeworks (NYSE:ZYME) on 1/20/2023
BeiGene, Ltd. stock logo
BGNE
BeiGene
$153.64
+0.5%
1/20/2023Target Raised bySVB Leerink-Outperform$236.00 -> $300.00LowView details for SVB Leerink rating of BeiGene (NASDAQ:BGNE) on 1/20/2023
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$156.58
+3.7%
1/20/2023Target Lowered bySVB Leerink-Outperform$194.00 -> $186.00LowView details for SVB Leerink rating of Johnson & Johnson (NYSE:JNJ) on 1/20/2023
Moderna, Inc. stock logo
MRNA
Moderna
$124.06
-0.9%
1/18/2023Target Raised bySVB LeerinkAnalyst M. ForooharMarket Perform$102.00 -> $111.00LowView details for SVB Leerink rating of Moderna (NASDAQ:MRNA) on 1/18/2023
Evolus, Inc. stock logo
EOLS
Evolus
$11.95
-0.6%
1/19/2023Target Raised bySVB Leerink-Outperform$18.00 -> $20.00LowView details for SVB Leerink rating of Evolus (NASDAQ:EOLS) on 1/19/2023
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$488.37
-0.1%
1/17/2023Upgraded bySVB Leerink-Market Perform -> Outperform$374.00LowView details for SVB Leerink rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/17/2023
Exact Sciences Co. stock logo
EXAS
Exact Sciences
$49.37
-0.6%
1/12/2023Target Raised bySVB Leerink-Outperform$70.00 -> $75.00LowView details for SVB Leerink rating of Exact Sciences (NASDAQ:EXAS) on 1/12/2023
Hologic, Inc. stock logo
HOLX
Hologic
$78.89
+0.5%
1/12/2023Target Raised bySVB Leerink-Outperform$85.00 -> $90.00LowView details for SVB Leerink rating of Hologic (NASDAQ:HOLX) on 1/12/2023
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$54.75
-0.6%
1/11/2023Target Lowered bySVB Leerink-Outperform$62.00 -> $61.00LowView details for SVB Leerink rating of Halozyme Therapeutics (NASDAQ:HALO) on 1/11/2023
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$38.37
-4.1%
1/10/2023Target Lowered bySVB Leerink-Outperform$50.00 -> $39.00LowView details for SVB Leerink rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 1/10/2023
Editas Medicine, Inc. stock logo
EDIT
Editas Medicine
$5.72
-4.0%
1/10/2023Target Lowered bySVB LeerinkAnalyst R. BienkowskiMarket Perform$7.00 -> $6.00LowView details for SVB Leerink rating of Editas Medicine (NASDAQ:EDIT) on 1/10/2023
Karyopharm Therapeutics Inc. stock logo
KPTI
Karyopharm Therapeutics
$0.98
-2.0%
1/10/2023Target Lowered bySVB Leerink-Market Perform$6.00 -> $5.00LowView details for SVB Leerink rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 1/10/2023
2seventy bio, Inc. stock logo
TSVT
2seventy bio
$4.77
-2.9%
1/10/2023Target Lowered bySVB Leerink-Outperform$41.00 -> $34.00LowView details for SVB Leerink rating of 2seventy bio (NASDAQ:TSVT) on 1/10/2023
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$15.24
-4.6%
1/9/2023Target Raised bySVB Leerink-Outperform$40.00 -> $45.00LowView details for SVB Leerink rating of Viridian Therapeutics (NASDAQ:VRDN) on 1/9/2023
bluebird bio, Inc. stock logo
BLUE
bluebird bio
$1.22
-9.6%
1/6/2023Target Raised bySVB Leerink-Market Perform$8.00 -> $9.00LowView details for SVB Leerink rating of bluebird bio (NASDAQ:BLUE) on 1/6/2023
Exact Sciences Co. stock logo
EXAS
Exact Sciences
$49.37
-0.6%
1/6/2023Target Raised bySVB Leerink-Outperform$60.00 -> $70.00LowView details for SVB Leerink rating of Exact Sciences (NASDAQ:EXAS) on 1/6/2023
Hologic, Inc. stock logo
HOLX
Hologic
$78.89
+0.5%
1/6/2023Target Raised bySVB Leerink-Outperform$78.00 -> $85.00LowView details for SVB Leerink rating of Hologic (NASDAQ:HOLX) on 1/6/2023
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$133.50
-1.9%
1/6/2023Target Raised bySVB Leerink-Outperform$160.00 -> $170.00LowView details for SVB Leerink rating of Agilent Technologies (NYSE:A) on 1/6/2023
AbCellera Biologics Inc. stock logo
ABCL
AbCellera Biologics
$3.37
-3.4%
1/6/2023Target Lowered bySVB Leerink-Outperform$20.00 -> $18.00LowView details for SVB Leerink rating of AbCellera Biologics (NASDAQ:ABCL) on 1/6/2023
908 Devices Inc. stock logo
MASS
908 Devices
$6.08
-1.5%
1/6/2023Target Lowered bySVB Leerink-Outperform$25.00 -> $20.00LowView details for SVB Leerink rating of 908 Devices (NASDAQ:MASS) on 1/6/2023
Repligen Co. stock logo
RGEN
Repligen
$132.31
-2.0%
1/6/2023Target Lowered bySVB Leerink-Outperform$230.00 -> $200.00LowView details for SVB Leerink rating of Repligen (NASDAQ:RGEN) on 1/6/2023
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$555.06
-0.1%
1/6/2023Target Raised bySVB Leerink-Outperform$555.00 -> $620.00LowView details for SVB Leerink rating of Thermo Fisher Scientific (NYSE:TMO) on 1/6/2023
Waters Co. stock logo
WAT
Waters
$314.38
-0.7%
1/6/2023Target Raised bySVB Leerink-Market Perform$320.00 -> $352.00LowView details for SVB Leerink rating of Waters (NYSE:WAT) on 1/6/2023
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
$4.46
-2.0%
1/6/2023Target Lowered bySVB Leerink-Outperform$62.00 -> $10.00N/AView details for SVB Leerink rating of Fate Therapeutics (NASDAQ:FATE) on 1/6/2023
Century Therapeutics, Inc. stock logo
IPSC
Century Therapeutics
$3.00
-8.8%
1/6/2023Target Lowered bySVB Leerink-Outperform$20.00 -> $14.00LowView details for SVB Leerink rating of Century Therapeutics (NASDAQ:IPSC) on 1/6/2023
Amedisys, Inc. stock logo
AMED
Amedisys
$97.75
+0.0%
1/5/2023Target Lowered bySVB Leerink-Market Perform$96.00 -> $85.00LowView details for SVB Leerink rating of Amedisys (NASDAQ:AMED) on 1/5/2023
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$8.98
-5.5%
1/5/2023Target Raised bySVB Leerink-Outperform$18.00 -> $20.00LowView details for SVB Leerink rating of Cogent Biosciences (NASDAQ:COGT) on 1/5/2023
Progyny, Inc. stock logo
PGNY
Progyny
$29.58
-1.4%
1/5/2023Reiterated bySVB LeerinkAnalyst S. DavisOutperform -> Market Perform$59.00 -> $34.00LowView details for SVB Leerink rating of Progyny (NASDAQ:PGNY) on 1/5/2023
Phreesia, Inc. stock logo
PHR
Phreesia
$24.53
+0.7%
1/5/2023Target Raised bySVB LeerinkAnalyst S. DavisOutperform$34.00 -> $39.00LowView details for SVB Leerink rating of Phreesia (NYSE:PHR) on 1/5/2023
Deciphera Pharmaceuticals, Inc. stock logo
DCPH
Deciphera Pharmaceuticals
$25.59
1/4/2023Target Raised bySVB Leerink-Outperform$25.00 -> $28.00LowView details for SVB Leerink rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 1/4/2023
Amgen Inc. stock logo
AMGN
Amgen
$335.67
+0.8%
12/22/2022Target Raised bySVB Leerink-Market Perform$256.00 -> $282.00LowView details for SVB Leerink rating of Amgen (NASDAQ:AMGN) on 12/22/2022
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$23.59
+1.0%
12/22/2022Target Lowered bySVB Leerink-Outperform$54.00 -> $50.00LowView details for SVB Leerink rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/22/2022
Madrigal Pharmaceuticals, Inc. stock logo
MDGL
Madrigal Pharmaceuticals
$269.40
-1.6%
12/20/2022Target Raised bySVB Leerink-Outperform$145.00 -> $315.00LowView details for SVB Leerink rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 12/20/2022
NewAmsterdam Pharma stock logo
NAMS
NewAmsterdam Pharma
$18.81
-2.5%
12/20/2022Initiated bySVB LeerinkAnalyst R. RuizOutperform$19.00LowView details for SVB Leerink rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 12/20/2022
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$81.37
-2.2%
12/16/2022Reiterated bySVB LeerinkAnalyst D. RisingerOutperform$60.00LowView details for SVB Leerink rating of Vaxcyte (NASDAQ:PCVX) on 12/16/2022
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$323.01
+1.3%
12/16/2022Target Raised bySVB Leerink-Outperform$238.00 -> $286.00LowView details for SVB Leerink rating of HCA Healthcare (NYSE:HCA) on 12/16/2022
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$905.41
-3.8%
12/16/2022Target Raised bySVB Leerink-Outperform$384.00 -> $410.00LowView details for SVB Leerink rating of Eli Lilly and Company (NYSE:LLY) on 12/16/2022
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.25
-3.1%
12/19/2022Target Raised bySVB Leerink-Outperform$8.00 -> $10.00LowView details for SVB Leerink rating of Roivant Sciences (NASDAQ:ROIV) on 12/19/2022
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$46.84
-3.4%
12/15/2022Target Raised bySVB LeerinkAnalyst M. KratkyMarket Perform$26.00 -> $31.00LowView details for SVB Leerink rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/15/2022
Wave Life Sciences Ltd. stock logo
WVE
Wave Life Sciences
$5.91
-1.3%
12/14/2022Target Raised bySVB LeerinkAnalyst M. ForooharMarket Perform$2.00 -> $7.00LowView details for SVB Leerink rating of Wave Life Sciences (NASDAQ:WVE) on 12/14/2022
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
$38.37
-4.1%
12/14/2022Target Raised bySVB Leerink-Outperform$49.00 -> $50.00LowView details for SVB Leerink rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 12/14/2022
Moderna, Inc. stock logo
MRNA
Moderna
$124.06
-0.9%
12/13/2022Target Raised bySVB LeerinkAnalyst M. ForooharMarket Perform$101.00 -> $102.00LowView details for SVB Leerink rating of Moderna (NASDAQ:MRNA) on 12/13/2022
Nurix Therapeutics, Inc. stock logo
NRIX
Nurix Therapeutics
$21.77
-4.6%
12/13/2022Target Lowered bySVB Leerink-Outperform$37.00 -> $28.00LowView details for SVB Leerink rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/13/2022
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$11.33
-0.1%
12/13/2022Initiated bySVB LeerinkAnalyst Roanna RuizOutperform$14.00LowView details for SVB Leerink rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 12/13/2022
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
$4.46
-2.0%
12/13/2022Target Lowered bySVB Leerink-Outperform$64.00 -> $62.00LowView details for SVB Leerink rating of Fate Therapeutics (NASDAQ:FATE) on 12/13/2022
BeiGene, Ltd. stock logo
BGNE
BeiGene
$153.64
+0.5%
12/12/2022Target Raised bySVB Leerink-Outperform$210.00 -> $236.00LowView details for SVB Leerink rating of BeiGene (NASDAQ:BGNE) on 12/12/2022
Affimed stock logo
AFMD
Affimed
$5.54
-0.2%
12/12/2022Target Lowered bySVB Leerink-Outperform$100.00 -> $60.00LowView details for SVB Leerink rating of Affimed (NASDAQ:AFMD) on 12/12/2022
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
$4.46
-2.0%
12/9/2022Target Lowered bySVB Leerink-Outperform$30.00 -> $22.00LowView details for SVB Leerink rating of Design Therapeutics (NASDAQ:DSGN) on 12/9/2022
Phreesia, Inc. stock logo
PHR
Phreesia
$24.53
+0.7%
12/9/2022Upgraded bySVB LeerinkAnalyst Stephanie DavisMarket Perform -> Outperform$31.00 -> $34.00LowView details for SVB Leerink rating of Phreesia (NYSE:PHR) on 12/9/2022
Replimune Group, Inc. stock logo
REPL
Replimune Group
$10.63
-3.9%
12/7/2022Target Raised bySVB Leerink-Outperform$30.00 -> $34.00LowView details for SVB Leerink rating of Replimune Group (NASDAQ:REPL) on 12/7/2022
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
$1.09
-12.8%
12/7/2022Target Lowered bySVB Leerink-Outperform$15.00 -> $10.00LowView details for SVB Leerink rating of Gossamer Bio (NASDAQ:GOSS) on 12/7/2022
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$23.59
+1.0%
12/6/2022Target Lowered bySVB Leerink-Outperform$56.00 -> $54.00LowView details for SVB Leerink rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 12/6/2022
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$181.97
-2.8%
12/2/2022Target Lowered bySVB Leerink-Outperform$242.00 -> $233.00LowView details for SVB Leerink rating of Veeva Systems (NYSE:VEEV) on 12/2/2022
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$27.36
+0.0%
12/2/2022Target Lowered bySVB Leerink-Outperform$90.00 -> $86.00LowView details for SVB Leerink rating of Intellia Therapeutics (NASDAQ:NTLA) on 12/2/2022
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$121.61
+2.8%
11/30/2022Initiated bySVB Leerink-OutperformLowView details for SVB Leerink rating of Lantheus (NASDAQ:LNTH) on 11/30/2022

MarketBeat Community Rating for SVB Leerink

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  26,610 (Vote Outperform)
Underperform Votes:  23,317 (Vote Underperform)
Total Votes:  49,927
MarketBeat's community ratings are surveys of what our community members think about SVB Leerink and other research firms. Vote "Outperform" if you believe SVB Leerink's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Leerink's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.